Wegovy becomes the first GLP-1 based therapy authorized for MASH, which affects roughly 5% of U.S. adults, according to the ...

The number of Americans taking weight loss drugs is skyrocketing. According to a study from the nonprofit FAIR Health, the ...

When the FDA took Novo Nordisk and Eli Lilly’s GLP-1 medications off of the drug shortage list, the move should have been a ...

Novo Nordisk's blockbuster weight-loss drug, Wegovy, received Food and Drug Administration approval to treat a serious ...

The label expansion could help Novo Nordisk “help shift the momentum” for Wegovy, after a difficult start to 2025, according ...

Scientists are developing dog weight loss drugs that work like Ozempic in humans, and they could be on the market as soon as ...

One of the latest trends in the health world, specifically for the Gen Z audience on the TikTok platform, is fibermaxxing — ...

Jealousy, secrecy, and lies are rippling through friendships, marriages, and even doctors’ appointments as GLP-1s go ...

The drug received accelerated approval for use in patients with metabolic dysfunction-associated steatohepatitis (MASH).

This episode of Pharma Pulse covers a new collaboration to expand access to GLP-1 therapies via LillyDirect, Pfizer’s Phase ...

But now, women have complained of 'Ozempic vulva' and its side effects. One woman on Reddit complained of 'pain when biking ...

U.S. prices for obesity-treatment pills that Eli Lilly and Novo Nordisk aim to launch next year likely will be on par with ...